Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGFA anticorps

VEGFA Reactivité: Humain, Rat, Souris, Chien, Lapin IHC, StM Hôte: Souris Monoclonal VEGF-1063 unconjugated
N° du produit ABIN6940867
  • Antigène Voir toutes VEGFA Anticorps
    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
    Reactivité
    • 154
    • 125
    • 98
    • 23
    • 20
    • 19
    • 19
    • 15
    • 12
    • 7
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain, Rat, Souris, Chien, Lapin
    Hôte
    • 204
    • 52
    • 13
    • 1
    • 1
    Souris
    Clonalité
    • 215
    • 55
    • 1
    Monoclonal
    Conjugué
    • 122
    • 41
    • 25
    • 12
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp VEGFA est non-conjugé
    Application
    • 206
    • 93
    • 65
    • 65
    • 50
    • 32
    • 27
    • 22
    • 22
    • 16
    • 15
    • 12
    • 10
    • 9
    • 8
    • 7
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (IHC), Staining Methods (StM)
    Specificité
    This MAb recognizes proteins of 19-22 kDa (reducing) and 38 kDa-44 kDa (non-reducing), identified as various isoforms of Vascular Endothelial Growth Factor or Vascular Permeability Factor (VEGF/VPF). It is highly specific to VEGF, which is a homodimeric, disulfide-linked glycoprotein with a close homology to platelet derived growth factor (PDGF). There are multiple isoforms of VEGF containing 206-, 189-, 165-, and 121-amino acid residues. The smaller two isoforms, VEGF165 and VEGF121, are secreted proteins and act as diffusible agents, whereas the larger two remain cell associated. VEGF/VPF plays an important role in angiogenesis, which promotes tumor progression and metastasis.
    Purification
    Purified by Protein A/G
    Immunogène
    Human VEGF189 recombinant protein
    Clone
    VEGF-1063
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product VEGFA Anticorps primaire
  • Indications d'application

    Positive Control: Tumor cells in astrocytomas, breast or ovarian carcinomas.

    Known Application: Immunohistochemistry (Formalin-fixed) (4-8 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 1 mM EDTA buffer, pH 8.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-80 °C
    Stockage commentaire
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Date de péremption
    24 months
  • Antigène
    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))
    Autre désignation
    VEGFA (VEGFA Produits)
    Synonymes
    anticorps MVCD1, anticorps VEGF, anticorps VPF, anticorps Vegf, anticorps Vegf120, anticorps Vegf164, anticorps Vegf188, anticorps Vpf, anticorps vegf, anticorps vegfa, anticorps wu:fj82c06, anticorps VEGF-A, anticorps VEGF164, anticorps eVEGF120, anticorps eVEGF164, anticorps vegf-a, anticorps vpf, anticorps vefg, anticorps si:dkey-14d8.3, anticorps wu:fd42e02, anticorps vascular endothelial growth factor A, anticorps vascular endothelial growth factor Aa, anticorps vascular endothelial growth factor A L homeolog, anticorps vascular endothelial growth factor Ab, anticorps VEGFA, anticorps Vegfa, anticorps vegfaa, anticorps vegfa.L, anticorps vegfa, anticorps vegfab
    Poids moléculaire
    19-22kDa (reducing) and 38kDa-44kDa (non-reducing)
    ID gène
    7422
    UniProt
    P15692
    Pathways
    Signalisation RTK, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
Support technique